Anyone who has recently had Botox is being urged to stay alert for symptoms that could appear days—or even weeks—after treatment, after UK health officials strengthened safety warnings following rare cases of botulism linked to botulinum toxin injections.
The Medicines and Healthcare products Regulatory Agency (MHRA) has updated safety information for all botulinum toxin type A products used in the UK after receiving reports of rare cases of iatrogenic botulism, a potentially life-threatening condition that can occur when the toxin spreads beyond the intended injection site. While the regulator stressed that the condition remains uncommon, it is urging patients to recognise the warning signs early and seek urgent medical attention if symptoms develop.
